Technology | January 25, 2012

Philips Releases Xper Flex Cardio System for Hemodynamic Monitoring

January 25, 2012 — Philips Healthcare announced the release of the Xper Flex Cardio Physiomonitoring system, a hemodynamic cardiac monitoring solution used to facilitate invasive investigation of heart and vascular disease. Equipped with advanced clinical decision support tools to assist clinicians in evaluating a patient's overall cardio performance, and general cardiovascular status, Xper Flex Cardio may also be used to display and analyze invasive blood pressure, surface electrocardiogram (ECG), respiration and other vital signs. The system is specifically designed for environments such as cath labs, EP labs and interventional radiology and cardiovascular Hybrid operating room (OR) environments.

The Xper Flex Cardio Physiomonitoring system presents several distinct advantages over previous systems, including traditional 12-lead interpretation of the resting ECG in addition to 16-lead analysis, enabling clinicians the freedom to choose which approach is most appropriate for each situation. The additional right chest and posterior leads used in 16-lead ECGs can provide information that may not be apparent on traditional 12-lead ECGs.

“Implementing Xper Flex Cardio has helped us enhance both the functionality and accuracy of our cath lab,” said Karen Keane, director, cardiac cath labs, Martin Memorial Medical Center.  “Its ability to analyze up to 16-leads of simultaneously-acquired ECG waveforms enables us to refine patient care, and its smaller size makes it the perfect system for our high-use, multi-function lab.”

Xper Flex Cardio also comes equipped with integrated fractional flow reserve (FFR) functionality—which provides data that could aid in treatment decisions, and a DXL ECG Algorithm analysis capability that uses multiple steps to produce precise and consistent ECG measurements that are used to generate interpretive statements. Additionally, the system has Culprit Artery Detection—a technology that provides suggestions on the probable site of an occlusion prior to cath procedure, saving valuable time and assisting with procedure planning—and patented ST Maps that provide a graphical indication of ST elevation.

The company also stated that it entered into an agreement with Volcano Corp, to ensure seamless experience for mutual customers of the Volcano SmartMap system.  Additionally, Philips has secured strong ties with FFR market leader St. Jude Medical.

 For more information: www.philips.com

Related Content

Baylis Medical and Siemens Co-Sponsor Transseptal Access Training Course
News | EP Lab| October 18, 2017
Baylis Medical Co. Inc. and Siemens Healthineers are co-sponsoring a first-of-its kind training program aimed at...
Societies Issue New Performance and Quality Measures for Treating Patients with Heart Attack
News | Cath Lab| October 17, 2017
The American College of Cardiology and the American Heart Association recently released updated clinical performance...
First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure| October 17, 2017
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S.
Dee Dee Wang runs Henry Ford Hospital's 3D printing lab for its complex structural heart cardiology program.

Dee Dee Wang, M.D., runs Henry Ford Hospital's 3-D printing lab that supports its complex structural heart program.

Feature | 3-D Printing| October 13, 2017 | Dave Fornell
Three-dimensional (3-D) printed anatomic models created from a patient’s computed tomography (CT), magnetic resonance...
Videos | Chronic Total Occlusion (CTO)| October 09, 2017
Bill Lombardi, M.D., director of complex coronary artery interventions at the University of Washington, discusses the
BTG Acquires Roxwood Medical
News | Business| October 05, 2017
BTG plc announced it has acquired Roxwood Medical, provider of advanced cardiovascular specialty catheters used in the...
TVA Medical Receives CE Mark for Next-Generation EverlinQ 4 EndoAVF System
News | Vascular Access| October 04, 2017
TVA Medical Inc. announced that its everlinQ 4 endoAVF System has received CE Mark in the European Union. The...
Reflow Medical's Wingman Crossing Catheter Receives FDA Clearance for Coronary Indication
News | Catheters| October 02, 2017
October 2, 2017 — Reflow Medical Inc. announced that the company has received 510(k) clearance from the U.S.
TherOx Gains FDA PMA Approval for SSO2 Therapy System
Technology | Cath Lab| September 29, 2017
September 29, 2017 — TherOx Inc. announced that the U.S.
Avinger Receives CE Mark for In-Stent Restenosis Indication With Pantheris Image-Guided Atherectomy
Technology | Atherectomy Devices| September 29, 2017
Avinger Inc. recently announced Conformité Européenne (CE) Marking approval for treating in-stent restenosis with the...
Overlay Init